CASI Pharmaceuticals, Inc. (CASI) Social Stream



CASI Pharmaceuticals, Inc. (CASI): $3.49

0.49 (+16.33%)

POWR Rating

Component Grades

Momentum

F

Stability

C

Sentiment

Quality

D

Add CASI to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#92 of 381

in industry

CASI PHARMACEUTICALS INC (CASI) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering CASI.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-08-13 3 $6 $3.5 $4.26 $6.15 -30.73%
2021-11-15 4 $6 $3.5 $4.26 $6.15 -30.73%
2022-03-29 4 $6 $3.8 $4.45 $6.15 -27.64%
2022-05-13 3 $60 $30 $45 $6.15 631.71%
2022-06-03 3 $60 $21 $37 $6.15 501.63%
2022-09-26 3 $35 $12 $22.666 $6.15 268.55%
2022-11-15 3 $35 $10 $22 $6.15 257.72%
2022-11-16 3 $35 $10 $18.333 $6.15 198.1%
2023-08-14 2 $10 $10 $10 $6.15 62.6%
2023-11-15 1 $12 $12 $12 $6.15 95.12%

Price Target Last Issued November 15, 2023

The Trend in the Analyst Price Target


CASI's average price target has moved up $7.55 over the prior 26 months.

Over the past 29 weeks, CASI's average upside potential has been 304.43%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-04-28 2 10 10 10 2.862 249.41%
2023-05-22 2 10 10 10 2.050 387.8%
2023-08-14 2 10 10 10 2.200 354.55%
2023-08-14 1 10 10 10 2.200 354.55%
2023-11-15 1 12 12 12 4.350 175.86%

CASI Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 1 0 0 0 0 1

The Trend in the Broker Recommendations


CASI's average broker recommendation rating improved by 0.67 over the prior 30 months.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In the context of all US stocks, CASI PHARMACEUTICALS INC's number of analysts covering the stock is higher than 111.78% of them.
  • To contextualize these metrics, consider that out of all US stocks, CASI PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is greater than 721.27% of them.
  • CASI has a higher average analyst price target than 230.37% of all US stocks.
  • CASI PHARMACEUTICALS INC's variance in analysts' estimates is lower than -822.06% of stocks in the small market cap category.

In the Pharmaceutical Products industry, GERN, VERU, and LFVN are the three stocks most similar to CASI PHARMACEUTICALS INC regarding the price target and analyst recommendation information presented here.

Make investment decisions regarding CASI using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!